These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12187166)

  • 1. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
    Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
    Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
    Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
    Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
    Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Cancer Screening in the Context of Clinical Guidelines: 2000 to 2012.
    Maroongroge S; Yu JB
    Am J Clin Oncol; 2018 Apr; 41(4):339-347. PubMed ID: 26886947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Medicare coverage on use of invasive colorectal cancer screening tests.
    Ko CW; Kreuter W; Baldwin LM
    Arch Intern Med; 2002 Dec 9-23; 162(22):2581-6. PubMed ID: 12456230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data sources for measuring colorectal endoscopy use among Medicare enrollees.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2118-27. PubMed ID: 17932360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.
    Chawla N; Yabroff KR; Mariotto A; McNeel TS; Schrag D; Warren JL
    Ann Epidemiol; 2014 Sep; 24(9):666-72, 672.e1-2. PubMed ID: 25066409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
    Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
    PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Identification Methods Among Kansas Medicare Beneficiaries, 2008-2010.
    Lai SM; Jungk J; Garimella S
    Prev Chronic Dis; 2015 Jul; 12():E107. PubMed ID: 26160293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age and comorbidity on colorectal cancer screening among older veterans.
    Walter LC; Lindquist K; Nugent S; Schult T; Lee SJ; Casadei MA; Partin MR
    Ann Intern Med; 2009 Apr; 150(7):465-73. PubMed ID: 19349631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.
    Schenck AP; Klabunde CN; Warren JL; Peacock S; Davis WW; Hawley ST; Pignone M; Ransohoff DF
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):799-804. PubMed ID: 18381471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic testing following fecal occult blood screening in the elderly.
    Lurie JD; Welch HG
    J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy.
    Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM
    J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.
    Klabunde CN; Legler JM; Warren JL; Baldwin LM; Schrag D
    Ann Epidemiol; 2007 Aug; 17(8):584-90. PubMed ID: 17531502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.